| Jeremy Brown, MD | |
|
3333 Riverbend Dr, Springfield, OR 97477-8800 | |
| (541) 222-7300 | |
| Not Available |
| Full Name | Jeremy Brown |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 3333 Riverbend Dr, Springfield, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073957148 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD176256 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
| Peacehealth Cottage Grove Community Medical Center | Cottage grove, OR | Hospital |
| Sacred Heart University District | Eugene, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eugene Emergency Physicians Pc | 2264330448 | 29 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.
A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.
Peter W. Atkinson, a University of California, Riverside professor of entomology and member of the university's Institute for Integrative Genome Biology, is part of a team that has linked the movement of small pieces of DNA, known as transposable elements, to a process called V(D)J recombination that produces the genetic diversity responsible for the production of antibodies.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1902892391 PECOS PAC ID: 1254242357 Enrollment ID: O20030922000023 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.
A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.
Peter W. Atkinson, a University of California, Riverside professor of entomology and member of the university's Institute for Integrative Genome Biology, is part of a team that has linked the movement of small pieces of DNA, known as transposable elements, to a process called V(D)J recombination that produces the genetic diversity responsible for the production of antibodies.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982774378 PECOS PAC ID: 4587573001 Enrollment ID: O20031215000598 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.
A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.
Peter W. Atkinson, a University of California, Riverside professor of entomology and member of the university's Institute for Integrative Genome Biology, is part of a team that has linked the movement of small pieces of DNA, known as transposable elements, to a process called V(D)J recombination that produces the genetic diversity responsible for the production of antibodies.
› Verified 6 days ago
| Entity Name | Eugene Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831133677 PECOS PAC ID: 2264330448 Enrollment ID: O20031226000011 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.
A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.
Peter W. Atkinson, a University of California, Riverside professor of entomology and member of the university's Institute for Integrative Genome Biology, is part of a team that has linked the movement of small pieces of DNA, known as transposable elements, to a process called V(D)J recombination that produces the genetic diversity responsible for the production of antibodies.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902892391 PECOS PAC ID: 1254242357 Enrollment ID: O20040513000725 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.
A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.
Peter W. Atkinson, a University of California, Riverside professor of entomology and member of the university's Institute for Integrative Genome Biology, is part of a team that has linked the movement of small pieces of DNA, known as transposable elements, to a process called V(D)J recombination that produces the genetic diversity responsible for the production of antibodies.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1578552402 PECOS PAC ID: 4587573001 Enrollment ID: O20061104000179 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.
A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.
Peter W. Atkinson, a University of California, Riverside professor of entomology and member of the university's Institute for Integrative Genome Biology, is part of a team that has linked the movement of small pieces of DNA, known as transposable elements, to a process called V(D)J recombination that produces the genetic diversity responsible for the production of antibodies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy Brown, MD Po Box 5920, Eugene, OR 97405-0911 Ph: () - | Jeremy Brown, MD 3333 Riverbend Dr, Springfield, OR 97477-8800 Ph: (541) 222-7300 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Thousands of independent studies in the past three years have revealed a strong connection between vitamin D deficiency and increased risk for a variety of serious illnesses including as many as 22 forms of cancer, heart disease, diabetes, osteoporosis and multiple sclerosis, as well as common colds and flus.
A new study using positron emission tomography (PET) determined PET is a more accurate way to diagnose recurrent melanoma than the present, standard procedures.
Peter W. Atkinson, a University of California, Riverside professor of entomology and member of the university's Institute for Integrative Genome Biology, is part of a team that has linked the movement of small pieces of DNA, known as transposable elements, to a process called V(D)J recombination that produces the genetic diversity responsible for the production of antibodies.
› Verified 6 days ago
Kevin Matthew Allan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3333 Riverbend Dr, Springfield, OR 97477 Phone: 541-344-8757 | |
Benjamin J Bronicel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1460 G St, Springfield, OR 97477 Phone: 541-726-4400 | |
Dr. Kevin Joseph Schoen, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1460 G St, Springfield, OR 97477 Phone: 541-726-4400 | |
Patrick Kelly, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3333 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-7300 | |
Dr. Jenna Lynn Shenk, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-8400 Fax: 541-222-8401 | |
Dr. Robert John Callahan Ii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3333 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6929 |